Cancer Immunotherapy Market to Exceed USD 119.3 Bn by 2021, Says M&M in Its Cutting-Edge Research Report Recently Added at

03 Oct 2016 • by Natalie Aster

LONDON – This year, the value of the worldwide market for cancer immunotherapy is estimated at almost USD 62 billion. It is anticipated to register growth at a 14% CAGR from 2016 to 2021. By 2021, the cancer immunotherapy market value will likely cross the USD 119.3 billion mark. Increasing healthcare expenditures, rising cancer incidence and increasing access to medical insurance across developed countries are amid the major factors driving growth in the world’s market for cancer immunotherapy. But, the market growth could be restrained by enhancing awareness of cancer therapy side-effects and stringent regulatory norms and policies.

The monoclonal antibodies sector is expected to see the highest CAGR in the next 5 years, spurred by such advantages of this therapy type as less recovery time and high success rate.

North America takes lead in the worldwide cancer immunotherapy market. It is followed by Europe and APAC. The big share of the North American market is attributed to increasing number of aged people and growing funding from non-government and government agencies to increase the research capacity.

New report “Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021” by MarketsandMarkets (M&M) gives access to trustworthy data on the world’s cancer immunotherapy market, contains a granular market assessment on the basis of geography, applications, therapy types and end-use sectors.

The research study explores the market dynamics, examines the competitive landscape, investigates the regulative environment, discusses the top trends, sheds light on the prevailing and emerging market trends, points out the major market growth challenges and opportunities. It profiles top market players, traces the recent industry developments and reviews the recent product launches and business activities in the market.

Additionally, the report highlights the key future growth prospects of the world’s cancer immunotherapy market and contains detailed future forecasts through 2021.

Many other insightful research reports by M&M are provided in this Market Publishers’ catalogue.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970